INTEGER HOLDINGS CORPORATION Repayments of Lines of Credit
INTEGER HOLDINGS CORPORATION (ITGR) reported Repayments of Lines of Credit of $157.60 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLinesOfCredit · last filed 2026-08-04
- INTEGER HOLDINGS CORPORATION repayments of lines of credit for the quarter ending 2026-07-03 was $110.80M, a 257.42% increase year-over-year.
- INTEGER HOLDINGS CORPORATION repayments of lines of credit for the quarter ending 2026-04-03 was $46.80M, a 86.32% decline year-over-year.
- INTEGER HOLDINGS CORPORATION repayments of lines of credit for the quarter ending 2025-12-31 was $6.00M, a 95.38% decline year-over-year.
- INTEGER HOLDINGS CORPORATION repayments of lines of credit for the quarter ending 2025-09-26 was $54.00M, a 18.18% decline year-over-year.
- INTEGER HOLDINGS CORPORATION repayments of lines of credit for fiscal 2025 was $433.00M, a 74.95% increase from fiscal 2024.
- INTEGER HOLDINGS CORPORATION repayments of lines of credit for fiscal 2024 was $247.50M, a 41.74% decline from fiscal 2023.
- INTEGER HOLDINGS CORPORATION repayments of lines of credit for fiscal 2023 was $424.80M, a 844.00% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION repayments of lines of credit for fiscal 2022 was $45.00M, a 28.57% decline from fiscal 2021.
| Period end | Repayments of Lines of Credit 3 month | Repayments of Lines of Credit 6 month | Repayments of Lines of Credit 9 month | Repayments of Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-07-03 | $110.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $157.60M 10-Q · filed 2026-08-04 | $163.60M derived: sum of 3 quarters · filed 2026-08-04 | $217.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-04-03 | $46.80M 10-Q · filed 2026-04-30 | $52.80M derived: sum of 2 quarters · filed 2026-04-30 | $106.80M derived: sum of 3 quarters · filed 2026-04-30 | $137.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $60.00M derived: sum of 2 quarters · filed 2026-02-23 | $91.00M derived: sum of 3 quarters · filed 2026-08-04 | $433.00M 10-K · filed 2026-02-23 |
| 2025-09-26 | $54.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $85.00M derived: sum of 2 quarters · filed 2026-08-04 | $427.00M 10-Q · filed 2025-10-23 | $557.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-27 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $373.00M 10-Q · filed 2026-08-04 | $503.00M derived: sum of 3 quarters · filed 2026-08-04 | $569.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-28 | $342.00M 10-Q · filed 2026-04-30 | $472.00M derived: sum of 2 quarters · filed 2026-04-30 | $538.00M derived: sum of 3 quarters · filed 2026-04-30 | $577.50M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $130.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $196.00M derived: sum of 2 quarters · filed 2026-02-23 | $235.50M derived: sum of 3 quarters · filed 2026-02-23 | $247.50M 10-K · filed 2026-02-23 |
| 2024-09-27 | $66.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $105.50M derived: sum of 2 quarters · filed 2025-10-23 | $117.50M 10-Q · filed 2025-10-23 | $188.31M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-28 | $39.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $51.50M 10-Q · filed 2025-07-24 | $122.31M derived: sum of 3 quarters · filed 2026-02-23 | $212.86M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-29 | $12.00M 10-Q · filed 2025-04-24 | $82.81M derived: sum of 2 quarters · filed 2026-02-23 | $173.36M derived: sum of 3 quarters · filed 2026-02-23 | $204.30M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $70.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $161.36M derived: sum of 2 quarters · filed 2026-02-23 | $192.30M derived: sum of 3 quarters · filed 2026-02-23 | $424.80M 10-K · filed 2026-02-23 |
| 2023-09-29 | $90.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $121.49M derived: sum of 2 quarters · filed 2024-10-24 | $353.99M 10-Q · filed 2024-10-24 | $359.99M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $30.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $263.44M 10-Q · filed 2024-07-25 | $269.44M derived: sum of 3 quarters · filed 2025-02-20 | $274.44M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $232.50M 10-Q · filed 2024-04-25 | $238.50M derived: sum of 2 quarters · filed 2025-02-20 | $243.50M derived: sum of 3 quarters · filed 2025-02-20 | $267.50M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $11.00M derived: sum of 2 quarters · filed 2025-02-20 | $35.00M derived: sum of 3 quarters · filed 2025-02-20 | $45.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $29.00M derived: sum of 2 quarters · filed 2023-10-26 | $39.00M 10-Q · filed 2023-10-26 | $57.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-07-01 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $34.00M 10-Q · filed 2023-07-27 | $52.00M derived: sum of 3 quarters · filed 2024-02-20 | $97.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-04-01 | $10.00M 10-Q · filed 2023-04-27 | $28.00M derived: sum of 2 quarters · filed 2024-02-20 | $73.00M derived: sum of 3 quarters · filed 2024-02-20 | $73.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $63.00M derived: sum of 2 quarters · filed 2024-02-20 | $63.00M derived: sum of 3 quarters · filed 2024-02-20 | $63.00M 10-K · filed 2024-02-20 |
| 2021-10-01 | $45.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $45.00M derived: sum of 2 quarters · filed 2022-10-27 | $45.00M 10-Q · filed 2022-10-27 | |
| 2021-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $0.00 10-Q · filed 2022-07-28 | ||
| 2021-04-02 | $0.00 10-Q · filed 2022-04-28 | |||
| 2020-10-02 | $120.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $135.00M 10-Q · filed 2021-10-28 | ||
| 2020-07-03 | $15.00M 10-Q · filed 2021-07-29 | |||
| 2019-09-27 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $25.00M 10-Q · filed 2020-10-29 | ||
| 2019-06-28 | $10.00M 10-Q · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |